Comparison of metabolism-mediated effects of pyrrolizidine alkaloids in a HepG2/C3A cell-S9 co-incubation system and quantification of their glutathione conjugates

References

• Chen T, Mei N, Fu PP. (2010). Genotoxicity of pyrrolizidine alkaloids. J Appl Toxicol 30:183–196.
   PubMed Web of Science ®Google Scholar
• Chen Z, Huo JR. (2010). Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. Neth J Med 68:252–260.
   PubMed Web of Science ®Google Scholar
• Chou MW, Jian Y, Williams LD, Xia Q, Churchwell M, Doerge DR, Fu PP. (2003a). Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid. Chem Res Toxicol 16:1130–1137.
   PubMed Web of Science ®Google Scholar
• Chou MW, Yan J, Nichols J, Xia Q, Beland FA, Chan PC, Fu PP. (2003b). Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F(1) mice. Cancer Lett 193:119–125.
   PubMed Web of Science ®Google Scholar
• Culvenor CC, Edgar JA, Jago MV, Qutteridge A, Peterson JE, Smith LW. (1976). Hepato- and pneumotoxicity of pyrrolizidine alkaloids and derivatives in relation to molecular structure. Chem Biol Interact 12:299–324.
   PubMed Web of Science ®Google Scholar
• Fletcher MT, McKenzie RA, Blaney BJ, Reichmann KG. (2009). Pyrrolizidine alkaloids in Crotalaria taxa from northern Australia: risk to grazing livestock. J Agric Food Chem 57:311–319.
   Google Scholar
• Flynn TJ, Ferguson MS. (2008). Multiendpoint mechanistic profiling of hepatotoxicants in HepG2/C3A human hepatoma cells and novel statistical approaches for development of a prediction model for acute hepatotoxicity. Toxicol In Vitro 22:1618–1631.
   Google Scholar
• Frahn JL, Culvenor CC, Mills JA. (1980). Preparative separation of the pyrrolizidine alkaloids, intermedine and lycopsamine, as their borate complexes. Journal of Chromatography, 195:379–383.
   Web of Science ®Google Scholar
• Fu PP, Xia Q, Lin G, Chou MW. (2004). Pyrrolizidine alkaloids–genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 36:1–55.
   PubMed Web of Science ®Google Scholar
• Fu PP, Yang YC, Xia Q, Chou MW, Cui YY, Lin G. (2002). Pyrrolizidine Alkaloids - Tumorigenic Components in Chinese Herbal Medicines and Dietary Supplements. J Food Drug Anal 10:198–211.
   Web of Science ®Google Scholar
• Gan J, Ruan Q, He B, Zhu M, Shyu WC, Humphreys WG. (2009). In vitro screening of 50 highly prescribed drugs for thiol adduct formation–comparison of potential for drug-induced toxicity and extent of adduct formation. Chem Res Toxicol 22:690–698.
   PubMed Web of Science ®Google Scholar
• Hincks JR, Kim HY, Segall HJ, Molyneux RJ, Stermitz FR, Coulombe RA Jr. (1991). DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure-activity relationships. Toxicol Appl Pharmacol 111:90–98.
   PubMed Web of Science ®Google Scholar
• Johnson BM, Bolton JL, van Breemen RB. (2001). Screening botanical extracts for quinoid metabolites. Chem Res Toxicol 14:1546–1551.
   PubMedGoogle Scholar
• Kakar F, Akbarian Z, Leslie T, Mustafa ML, Watson J, van Egmond HP, Omar MF, Mofleh J. (2010). An outbreak of hepatic veno-occlusive disease in Western afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids. J Toxicol 2010:313280.
   Google Scholar
• Kempf M, Reinhard A, Beuerle T. (2010). Pyrrolizidine alkaloids (PAs) in honey and pollen-legal regulation of PA levels in food and animal feed required. Mol Nutr Food Res 54:158–168.
   PubMed Web of Science ®Google Scholar
• Lamé MW, Morin D, Jones AD, Segall HJ, Wilson DW. (1990). Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline. Toxicol Lett 51:321–329.
   PubMed Web of Science ®Google Scholar
• Lin G, Cui YY, Hawes EM. (2000). Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid. Drug Metab Dispos 28:1475–1483.
   PubMed Web of Science ®Google Scholar
• Mattocks AR. (1981). Relation of structural features to pyrrolic metabolites in livers of rats given pyrrolizidine alkaloids and derivatives. Chem Biol Interact 35:301–310.
   PubMedGoogle Scholar
• Mattocks AR. (1982). Hydrolysis and hepatotoxicity of retronecine diesters. Toxicol Lett 14:111–116.
   PubMed Web of Science ®Google Scholar
• Mattocks AR. (1986). Chemistry and toxicology of pyrrolizidine alkaloids. Academic Press, London.
   Google Scholar
• Mattocks AR, Croswell S, Jukes R, Huxtable RJ. (1991). Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver. Toxicon 29:409–415.
   PubMed Web of Science ®Google Scholar
• Mattocks AR, Jukes R, Brown J. (1989). Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon 27:561–567.
   PubMed Web of Science ®Google Scholar
• Mattocks AR, White IN. (1971). The conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat-liver microsomes in vitro. Chem Biol Interact 3:383–396.
   PubMed Web of Science ®Google Scholar
• Mei N, Guo L, Fu PP, Fuscoe JC, Luan Y, Chen T. (2010). Metabolism, genotoxicity, and carcinogenicity of comfrey. J Toxicol Environ Health B Crit Rev 13:509–526.
   PubMed Web of Science ®Google Scholar
• Miranda CL, Reed RL, Guengerich FP, Buhler DR. (1991). Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver. Carcinogenesis 12:515–519.
   PubMed Web of Science ®Google Scholar
• Otto M, Hansen SH, Dalgaard L, Dubois J, Badolo L. (2008). Development of an in vitro assay for the investigation of metabolism-induced drug hepatotoxicity. Cell Biol Toxicol 24:87–99.
   PubMed Web of Science ®Google Scholar
• Pawar RS, Grundel E, Mazzola E, White KD, Krynitsky AJ, Rader JI. (2010). Chiral stationary phases for separation of intermedine and lycopsamine enantiomers from Symphytum uplandicum. J Sep Sci 33:200–205.
   Google Scholar
• Prakash AS, Pereira TN, Reilly PE, Seawright AA. (1999). Pyrrolizidine alkaloids in human diet. Mutat Res 443:53–67.
   PubMed Web of Science ®Google Scholar
• Ramsdell HS, Kedzierski B, Buhler DR. (1987). Microsomal metabolism of pyrrolizidine alkaloids from Senecio jacobaea. Isolation and quantification of 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine and N-oxides by high performance liquid chromatography. Drug Metab Dispos 15:32–36.
   Google Scholar
• Robertson KA, Seymour JL, Hsia MT, Allen JR. (1977). Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione. Cancer Res 37:3141–3144.
   PubMed Web of Science ®Google Scholar
• Roeder E. (1995). Medicinal plants in Europe containing pyrrolizidine alkaloids. Pharmazie 50:83–98.
   PubMed Web of Science ®Google Scholar
• Roeder E. (2000). Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie 55:711–726.
   PubMed Web of Science ®Google Scholar
• Soglia JR, Contillo LG, Kalgutkar AS, Zhao S, Hop CE, Boyd JG, Cole MJ. (2006). A semiquantitative method for the determination of reactive metabolite conjugate levels in vitro utilizing liquid chromatography-tandem mass spectrometry and novel quaternary ammonium glutathione analogues. Chem Res Toxicol 19:480–490.
   PubMed Web of Science ®Google Scholar
• Stickel F, Seitz HK. (2000). The efficacy and safety of comfrey. Public Health Nutr 3:501–508.
   PubMed Web of Science ®Google Scholar
• Weston CF, Cooper BT, Davies JD, Levine DF. (1987). Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br Med J (Clin Res Ed) 295:183.
   PubMedGoogle Scholar
• Wiedenfeld H. (2011). Plants containing pyrrolizidine alkaloids: toxicity and problems. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 28:282–292.
   PubMed Web of Science ®Google Scholar
• Wiedenfeld H, Edgar JA. (2011). Toxicity of pyrrolizidine alkaloids to humans and ruminants. Phytochemical Reviews 10:137–151.
   Web of Science ®Google Scholar
• Yan CC, Cooper RA, Huxtable RJ. (1995). The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver. Toxicol Appl Pharmacol 133:277–284.
   PubMed Web of Science ®Google Scholar
• Yeong ML, Swinburn B, Kennedy M, Nicholson G. (1990). Hepatic veno-occlusive disease associated with comfrey ingestion. J Gastroenterol Hepatol 5:211–214.
   PubMed Web of Science ®Google Scholar